Recombinant Candida glabrata 40S ribosomal protein S23 (RPS23)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: We will prioritize shipping the format currently in stock. If you require a specific format, please specify this in your order notes, and we will fulfill your request to the best of our ability.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping is available upon request; please contact us in advance as additional fees will apply.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and may serve as a useful reference.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and the protein's inherent stability.
Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The specific tag will be determined during production. If you require a particular tag type, please inform us, and we will prioritize its implementation.
Synonyms
RPS23; CAGL0L04840g; 40S ribosomal protein S23
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-145
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) (Yeast) (Torulopsis glabrata)
Target Names
RPS23
Target Protein Sequence
MGKGKPRGLN SARKLRVHRR NNRWAENNYK KRLLGTAFKS SPFGGSSHAK GIVLEKLGIE SKQPNSAIRK CVRVQLIKNG KKVTAFVPND GCLNFVDEND EVLLAGFGRK GKAKGDIPGV RFKVVKVSGV SLLALWKEKK EKPRS
Uniprot No.

Q&A

What is the basic structure and function of RPS23 in Candida glabrata?

RPS23 is a critical component of the 40S ribosomal subunit in Candida glabrata, belonging to the S12P family of ribosomal proteins. Like its homologs in other species, C. glabrata RPS23 is located in the cytoplasm and plays an essential role in protein synthesis machinery . The protein shares significant amino acid sequence similarity with Saccharomyces cerevisiae ribosomal protein S28, reflecting evolutionary conservation among fungal species .

How conserved is RPS23 across fungal species compared to human RPS23?

RPS23 demonstrates remarkable evolutionary conservation across fungal species and even between fungi and humans, particularly within functional domains involved in ribosome assembly and function. Comparative sequence analysis reveals that:

SpeciesSequence Identity to C. glabrata RPS23Conserved Functional Domains
Saccharomyces cerevisiae~85-90%S12P domain, RNA binding sites
Candida albicans~82-87%S12P domain, RNA binding sites
Aspergillus fumigatus~75-80%S12P domain, RNA binding sites
Homo sapiens~70-75%S12P domain, RNA binding sites

What are the typical expression patterns of RPS23 in different growth phases of Candida glabrata?

Interestingly, research on related pathways suggests that under hypoxic conditions, which C. glabrata may encounter during host colonization, expression patterns may be modulated by transcription factors such as SrbA orthologs . This adaptation allows the pathogen to adjust its translation apparatus according to the microenvironment.

What are the optimal methods for expressing recombinant C. glabrata RPS23?

The expression of recombinant C. glabrata RPS23 presents several technical challenges that require specific methodological approaches:

Expression SystemAdvantagesLimitationsOptimization Strategies
E. coli (BL21)High yield, simplicityPotential misfolding, lack of PTMsUse of fusion tags (His6, GST), expression at lower temperatures (18-25°C)
Yeast (S. cerevisiae)Native-like folding, appropriate PTMsLower yield than bacterial systemsCodon optimization, use of strong inducible promoters (GAL1)
Insect cell systemsGood for soluble expression, PTMsHigher cost, longer production timeBaculovirus optimization, addition of chaperones

For structural and functional studies, a common approach involves:

  • Gene synthesis with codon optimization for the selected expression system

  • Cloning into a vector with an N-terminal His6-tag and a precision protease cleavage site

  • Expression in E. coli at reduced temperatures (18°C) after IPTG induction

  • Purification using Ni-NTA affinity chromatography followed by size exclusion chromatography

This approach typically yields 5-10 mg of purified protein per liter of culture, sufficient for most biochemical and structural analyses.

What analytical techniques are most effective for studying RPS23 structure and interactions?

Multiple complementary techniques are recommended for comprehensive analysis of C. glabrata RPS23:

Analytical TechniqueApplicationResolution/Information Obtained
X-ray Crystallography3D structure determinationAtomic resolution (1.5-3Å)
Cryo-EMStructure in ribosomal contextNear-atomic resolution (2.5-4Å)
NMR SpectroscopyDynamic properties, ligand bindingAtomic-level interactions in solution
Hydrogen-Deuterium Exchange MSProtein dynamics, interaction interfacesPeptide-level resolution of solvent accessibility
Cross-linking Mass SpectrometryProtein-protein interaction sitesAmino acid-level resolution of proximity
Surface Plasmon ResonanceBinding kineticsReal-time association/dissociation constants

For protein-protein interaction studies, a combination of cross-linking followed by mass spectrometry has proven particularly valuable. This approach has successfully identified interaction hotspots between ribosomal proteins and potential regulatory factors, similar to the methodologies used to study SrbA interactions in other fungal systems .

How does RPS23 contribute to Candida glabrata pathogenicity and virulence?

The contribution of RPS23 to C. glabrata pathogenicity appears to be multifaceted:

  • Translational adaptation: RPS23 enables selective translation of stress-responsive and virulence-associated mRNAs during host colonization and infection.

  • Stress response integration: Similar to other ribosomal proteins, RPS23 likely functions beyond its structural role in ribosomes to modulate stress responses, particularly under the hypoxic conditions encountered during infection.

  • Glutathione metabolism: Research indicates that glutathione metabolism is essential for C. glabrata virulence, and ribosomal proteins like RPS23 may influence this pathway through translational control of key enzymes .

  • Biofilm formation: Preliminary evidence suggests that alterations in ribosomal protein expression, including RPS23, correlate with biofilm formation capacity, a key virulence trait of C. glabrata.

Given its essential nature, RPS23 itself is not typically categorized as a classical virulence factor, but rather as part of the core machinery that enables the expression of actual virulence determinants and stress adaptation proteins.

What role does RPS23 play in antifungal resistance mechanisms in Candida glabrata?

C. glabrata exhibits intrinsic resistance to several antifungals, with ribosomal proteins potentially contributing to this phenotype through several mechanisms:

Resistance MechanismRPS23 InvolvementExperimental Evidence
Translational stress responseEnhanced translation of resistance genesDifferential ribosome profiling during drug exposure
Metabolic adaptationTranslation of enzymes involved in drug detoxificationProteomic shifts in enzyme abundance
Biofilm-associated resistanceAltered translation during biofilm formationTranscriptome-proteome correlation studies

Research strategies to investigate RPS23's specific role in resistance should include:

  • CRISPR interference to modulate RPS23 expression without complete depletion

  • Ribosome profiling in drug-sensitive vs. resistant strains

  • Mass spectrometry to identify post-translational modifications in response to drug exposure

  • Comparative analysis with closely related Candida species with different resistance profiles

These approaches could reveal whether RPS23 represents a potential target for adjuvant therapies to enhance antifungal efficacy.

How can protein-protein interaction networks involving RPS23 be characterized in C. glabrata?

Understanding the protein interaction network of RPS23 is crucial for elucidating its functions beyond the ribosome. Advanced methodologies for this characterization include:

  • Affinity purification coupled with mass spectrometry (AP-MS):

    • Expressing tagged RPS23 in C. glabrata

    • Performing pull-downs under various growth conditions

    • Identifying co-purifying proteins by mass spectrometry

  • Proximity labeling approaches:

    • Using BioID or APEX2 fusions with RPS23

    • Allowing in vivo labeling of proximal proteins

    • Purifying and identifying biotinylated proteins

  • Three-dimensional structural predictions and hotspot analyses:
    Similar to methods used for SrbA interaction studies , computational prediction of protein structure and interaction interfaces can provide valuable insights:

    • Protein structure modeling using tools like AlphaFold

    • Interaction site prediction using tools similar to ClusPro and KFC2

    • Validation of predicted interactions by mutagenesis of key residues

  • Crosslinking mass spectrometry (XL-MS):

    • Capturing transient interactions through chemical crosslinking

    • Identifying interaction sites at amino acid resolution

These approaches have revealed that transcription factors like SrbA can interact with various metabolic enzymes and proteins involved in cell cycle regulation , suggesting RPS23 might similarly engage in regulatory interactions beyond its structural role in ribosomes.

What are the most promising approaches for targeting RPS23 in antifungal development?

The essential nature and structural differences between fungal and human RPS23 make it a potential target for novel antifungal development. Promising approaches include:

  • Structure-based drug design:

    • Solving high-resolution structures of C. glabrata RPS23

    • Identifying unique pockets or interfaces absent in human homologs

    • Virtual screening of compound libraries against these targets

    • Fragment-based approaches to develop highly specific inhibitors

  • Peptide-based inhibitors:

    • Designing peptides that mimic natural binding partners

    • Targeting RPS23 interactions specific to fungal ribosomes

    • Employing stapled peptides for enhanced stability and cellular penetration

  • RNA-targeted approaches:

    • Antisense oligonucleotides targeting RPS23 mRNA

    • Small molecules that disrupt RPS23 mRNA structure

  • Combination strategies:

    • Identifying synergistic effects between RPS23 inhibitors and existing antifungals

    • Targeting multiple ribosomal proteins simultaneously

Screening methodologies should include both in vitro translation assays and whole-cell approaches to identify compounds with both target specificity and cellular efficacy.

What are the main technical challenges in studying C. glabrata RPS23 and how can they be overcome?

Researchers face several significant challenges when studying C. glabrata RPS23:

ChallengeImpactRecommended Solution
Essential gene natureDifficulty in genetic manipulationConditional expression systems, partial depletion with CRISPR interference
Integration into large complexesChallenging for structural studiesCryo-EM of intact ribosomes, selective labeling strategies
High conservationSpecificity for targetingFocus on subtle structural differences, species-specific interactions
Post-translational modificationsFunctional complexityAdvanced mass spectrometry, site-specific mutagenesis

Emerging technologies to address these challenges include:

  • Microfluidic approaches for single-cell analysis of ribosome function

  • Nanobody development for specific detection and perturbation of RPS23 in its native context

  • Time-resolved cryo-EM to capture dynamic states of ribosomes during translation

  • In situ structural biology techniques to study RPS23 within intact cells

What future research directions will advance our understanding of RPS23 biology in pathogenic fungi?

Several promising research avenues could significantly advance our understanding of RPS23 biology:

  • Specialized ribosomes: Investigating whether C. glabrata produces ribosomes with altered RPS23 states (modifications or paralogs) to selectively translate specific mRNAs during stress or host interaction.

  • Moonlighting functions: Exploring potential extraribosomal roles of RPS23, particularly in signaling pathways relevant to pathogenesis, similar to how SrbA participates in multiple regulatory interactions .

  • Host-pathogen interface: Examining whether RPS23 or ribosome-derived fragments interact with host factors during infection.

  • Evolutionary adaptations: Comparative analysis across Candida species to identify pathogen-specific adaptations in RPS23 structure and function.

  • Translational regulation networks: Mapping how RPS23 contributes to selective translation during stress response, potentially involving interaction with transcription factors like SrbA orthologs in C. glabrata .

Integration of multi-omics approaches—combining transcriptomics, proteomics, structural biology, and functional genetics—will be essential to fully elucidate the complex roles of RPS23 in fungal pathobiology.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.